Atlas Trials

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Clinical trial NCT03521934 · TERMINATED

Trial details

NCT number
NCT03521934
Sponsor
Lexicon Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Heart FailureType 2 Diabetes Mellitus
Start date
2018-06-15
Primary completion
2020-06-05
Enrollment
1222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.